Areas of Excellence
Using Data to Transform Diabetes Care and Patient Lives
Total Funding Approved
- over HK$80M
Coordinating Institution
- The Chinese University of Hong Kong (Professor Ronald Ma Ching-wan)
Diabetes is a common medical condition that affects more than 10% of the population in Hong Kong and more than 530 million people worldwide, creating a heavy burden on society. The Diabetes and Endocrine Research Group at CUHK has been devoted to diabetes research for the past three decades, translating knowledge into prevention and treatment strategies. Led by Professor Ronald Ma, this project aims to bridge the existing gaps in diabetes prevention, treatment and professional education by leveraging CUHK’s resources, experience, and local and international partnerships.
This project builds on the 2020 Lancet Commission Report[1] prepared by CUHK’s Professor Juliana Chan Chung-ngor and the Diabetes and Endocrine Research Group, as well as three decades of research, care and education pioneered by the project team, supported by their long-term partners in the fields of public health, epidemiology, surgery, family medicine, psychology and behavioural science. The project team hopes to transform diabetes care and patients’ lives, and turn Hong Kong into a global centre of excellence for innovative medicine, translational research, education and care.
[1] In 2020, Professor Juliana Chan led preparation of the Lancet Commission Report on Diabetes, in which 44 global experts spent 4 years to review, critique and synthesise evidence; identified major gaps in prevention, treatment, care and professional education in diabetes, and provided roadmap to reduce burden of diabetes and chronic diseases.